Published in Br J Anaesth on January 01, 1996
Double blind comparison of combination of 0.1% ropivacaine and fentanyl to combination of 0.1% bupivacaine and fentanyl for extradural analgesia in labour. J Anaesthesiol Clin Pharmacol (2016) 0.88
Progress in analgesia for labor: focus on neuraxial blocks. Int J Womens Health (2010) 0.78
Maternal and foetal outcome after epidural labour analgesia in high-risk pregnancies. Indian J Anaesth (2016) 0.75
Comparative Efficacy of Minimal Concentration of Racemic Bupivacaine (0.0625%) with Fentanyl and Ropivacaine (0.1%) with Fentanyl for Epidural Labor Analgesia. Anesth Essays Res (2017) 0.75
RNA virus mutations and fitness for survival. Annu Rev Microbiol (1997) 10.06
Mutation rates among RNA viruses. Proc Natl Acad Sci U S A (1999) 6.37
Rapid evolution of RNA viruses. Annu Rev Microbiol (1987) 5.97
Specific cleavage of viral proteins as steps in the synthesis and maturation of enteroviruses. Proc Natl Acad Sci U S A (1968) 5.64
Basic concepts in RNA virus evolution. FASEB J (1996) 3.35
Magnetic resonance imaging of extradural blood patches: appearances from 30 min to 18 h. Br J Anaesth (1993) 2.87
Genetic and fitness changes accompanying adaptation of an arbovirus to vertebrate and invertebrate cells. J Virol (1999) 2.78
Determination of molar ratios of vesicular stomatitis virus induced RNA species in BHK21 cells. Biochemistry (1976) 2.69
A yeast RNA-binding protein shuttles between the nucleus and the cytoplasm. Mol Cell Biol (1994) 2.66
Exponential increases of RNA virus fitness during large population transmissions. Proc Natl Acad Sci U S A (1995) 2.60
Direct method for quantitation of extreme polymerase error frequencies at selected single base sites in viral RNA. J Virol (1986) 2.41
Effects of defective interfering viruses on virus replication and pathogenesis in vitro and in vivo. Adv Virus Res (1991) 2.38
Hand positions and the "son-of-Doughty" technique. Anaesthesia (2005) 2.36
Persistent noncytocidal vesicular stomatitis virus infections mediated by defective T particles that suppress virion transcriptase. Proc Natl Acad Sci U S A (1974) 2.34
Sequences of the major antibody binding epitopes of the Indiana serotype of vesicular stomatitis virus. Virology (1986) 2.29
Lack of evolutionary stasis during alternating replication of an arbovirus in insect and mammalian cells. J Mol Biol (1999) 2.28
Long term backache after childbirth: prospective search for causative factors. BMJ (1996) 2.27
Lack of evidence for proofreading mechanisms associated with an RNA virus polymerase. Gene (1992) 2.20
Absence of transcriptase activity or transcription-inhibiting ability in defective interfering particles of vesicular stomatitis virus. Virology (1972) 2.18
Size of genetic bottlenecks leading to virus fitness loss is determined by mean initial population fitness. J Virol (1995) 2.18
Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study. Neurology (2008) 2.16
Back pain, pregnancy, and childbirth. BMJ (1997) 2.14
Vesicular stomatitis virus defective interfering particles can contain extensive genomic sequence rearrangements and base substitutions. Cell (1984) 2.13
RNA virus quasispecies populations can suppress vastly superior mutant progeny. J Virol (1990) 2.12
Subclonal components of consensus fitness in an RNA virus clone. J Virol (1994) 2.09
RNA virus quasispecies: significance for viral disease and epidemiology. Infect Agents Dis (1994) 2.08
Self-poisoning and self-injury in the Oxford area. Epidemiological aspects 1969-73. Br J Prev Soc Med (1975) 2.06
Prophylaxis and immunization in mice by use of virus-free defective T particles to protect against intracerebral infection by vesicular stomatitis virus. Proc Natl Acad Sci U S A (1973) 2.05
Evolution of multiple genome mutations during long-term persistent infection by vesicular stomatitis virus. Cell (1979) 2.04
High nucleotide substitution error frequencies in clonal pools of vesicular stomatitis virus. J Virol (1989) 2.04
Assessing long term backache after childbirth. BMJ (1993) 2.03
Dural puncture and headache. BMJ (1993) 2.01
Ribonucleic acid and protein synthesis in mitotic HeLa cells. J Cell Biol (1965) 1.98
Extreme heterogeneity in populations of vesicular stomatitis virus. J Virol (1989) 1.95
Chromatographic alterations in transfer RNA's accompanying speciation, differentiation and tumor formation. J Mol Biol (1968) 1.88
Efficient, inefficient, and abortive infection of different mammalian cells by small RNA viruses. Virology (1967) 1.88
Very high frequency of reversion to guanidine resistance in clonal pools of guanidine-dependent type 1 poliovirus. J Virol (1990) 1.87
Evolution of alphaviruses in the eastern equine encephalomyelitis complex. J Virol (1994) 1.86
Extreme fitness differences in mammalian and insect hosts after continuous replication of vesicular stomatitis virus in sandfly cells. J Virol (1995) 1.84
Synthesis of poly(A) in vitro by purified virions of vesicular stomatitis virus. Nat New Biol (1973) 1.83
Ocular and cardiovascular effects of local and systemic pindolol. Br J Ophthalmol (1979) 1.81
Sequence of a RNA templated by the 3'-OH RNA terminus of defective interfering particles of vesicular stomatitis virus. Proc Natl Acad Sci U S A (1978) 1.80
Carbohydrate composition of the membrane glycoprotein of vesicular stomatitis virus grown in four mammalian cell lines. Proc Natl Acad Sci U S A (1974) 1.78
Synthesis and cleavage of enterovirus polypeptides in mammalian cells. J Virol (1970) 1.73
Factors involved in the generation and replication of rhabdovirus defective T particles. J Virol (1976) 1.72
Sciatic nerve palsy following childbirth. Anaesthesia (1996) 1.71
Long-term persistent vesicular stomatitis virus and rabies virus infection of cells in vitro. J Gen Virol (1976) 1.71
A simple technique to reduce the incidence of accidental dural puncture. Anaesthesia (2001) 1.71
Membrane and nonmembrane proteins of mammalian cells. Synthesis, turnover, and size distribution. Biochemistry (1970) 1.64
Influenza virus effects on cell membrane proteins. Science (1970) 1.62
Logic in the safe practice of spinal anaesthesia. Anaesthesia (2000) 1.61
High frequency of single-base transitions and extreme frequency of precise multiple-base reversion mutations in poliovirus. Proc Natl Acad Sci U S A (1992) 1.60
Exponential fitness gains of RNA virus populations are limited by bottleneck effects. J Virol (1999) 1.60
Processing of the 5' end of Escherichia coli 16S ribosomal RNA. Proc Natl Acad Sci U S A (1978) 1.59
People who deliberately poison or injure themselves: their problems and their contacts with helping agencies. Psychol Med (1977) 1.59
Cell-mediated immunity to vesicular stomatitis virus infections in mice. Exp Cell Biol (1978) 1.57
Extradural opioids in labour. Br J Anaesth (1989) 1.57
Virus-induced interference in heterologously infected HeLa cells. J Virol (1972) 1.57
Purification of defective interfering T particles of vesicular stomatitis and rabies viruses generated in vivo in brains of newborn mice. Virology (1975) 1.54
Toxicity of norpethidine in sickle cell crisis. BMJ (1992) 1.52
Role of defective interfering particles of Sendai virus in persistent infections. Virology (1979) 1.52
Ethics and clinical research in obstetric anaesthesia. Lancet (1992) 1.51
Impact of a stepwise protocol for treating pain on pain intensity in nursing home patients with dementia: a cluster randomized trial. Eur J Pain (2014) 1.50
Ultrasound venous access simulation: the Italian job. Emerg Med J (2009) 1.49
Coupled in vitro transcription and translation of vesicular stomatitis virus messenger RNA. Proc Natl Acad Sci U S A (1975) 1.48
Developmental changes in cortisol secretion in normal and at-risk youth. Dev Psychopathol (2001) 1.48
High multiplicities of infection favor rapid and random evolution of vesicular stomatitis virus. Virology (1982) 1.47
Can pre-emptive lumbar epidural blockade reduce postoperative pain following lower abdominal surgery? Anaesthesia (1993) 1.46
Negative effects of chemical mutagenesis on the adaptive behavior of vesicular stomatitis virus. J Virol (1997) 1.45
Salivary phenytoin concentrations in epilepsy and in chronic renal failure. Lancet (1976) 1.43
Carbohydrate composition of the membrane glycoprotein of vesicular stomatitis virus. Virology (1974) 1.42
Life-saving or ineffective? An observational study of the use of cricoid pressure and maternal outcome in an African setting. Int J Obstet Anesth (2009) 1.42
The effects of maternal epidural anaesthesia on neonatal behaviour during the first month. Dev Med Child Neurol (1994) 1.41
Virus-directed protein synthesis in different animal and human cells. Science (1968) 1.41
RNA polymerase activity and poly(A) synthesizing activity in defective T particles of vesicular stomatitis virus. Virology (1974) 1.41
Maternal sequelae of childbirth. Br J Anaesth (1995) 1.41
Uptake and metabolism of a dual fluorochrome Tat-nanoparticle in HeLa cells. Bioconjug Chem (2003) 1.39
The effect of epidural opioids on maternal oxygenation during labour and delivery. Anaesthesia (1996) 1.39
Assessing bupivacaine 10 mg/fentanyl 20 microg as an intrathecal test dose. Int J Obstet Anesth (2003) 1.39
Comparison of the maternal and fetal effects associated with intermittent or continuous infusion of extradural analgesia. Br J Anaesth (1992) 1.38
Ropivacaine. Anaesthesia (1991) 1.38
The effect of anaesthesia of the airway in dog and man: a study of respiratory reflexes, sensations and lung mechanics. Clin Sci Mol Med (1976) 1.36
Does the major histocompatibility complex serve as a specific receptor for Semliki Forest virus? J Virol (1980) 1.34
A comparison of the potential toxicity of bupivacaine, lignocaine and mepivacaine during epidural blockade for surgery. Br J Anaesth (1971) 1.33
Properties of DI particle resistant mutants of vesicular stomatitis virus isolated from persistent infections and from undiluted passages. Cell (1983) 1.31
SEC3 mutations are synthetically lethal with profilin mutations and cause defects in diploid-specific bud-site selection. Genetics (1996) 1.31
The transient expression of type II collagen at tissue interfaces during mammalian craniofacial development. Development (1991) 1.28
Diversity within natural populations of eastern equine encephalomyelitis virus. Virology (1993) 1.27
Studies on the in vitro transcription and translation of vesicular stomatitis virus mRNA. Virology (1976) 1.26
Vesicular stomatitis virus mutants resistant to defective-interfering particles accumulate stable 5'-terminal and fewer 3'-terminal mutations in a stepwise manner. J Virol (1984) 1.25
Viral quasispecies and the problem of vaccine-escape and drug-resistant mutants. Prog Drug Res (1997) 1.21
Denatured DNA as a direct template for in vitro protein synthesis. Proc Natl Acad Sci U S A (1965) 1.21
Proteinase activity in purified animal viruses. Biochem Biophys Res Commun (1972) 1.21
Attempts to detect homologous autointerference in vivo with influenza virus and vesicular stomatitis virus. Infect Immun (1973) 1.21
Similarities and differences among specific tRNA's in mammalian tissues. Proc Natl Acad Sci U S A (1967) 1.15
Generation of defective interfering particles in picornaviruses. Virology (1980) 1.15
Evolution of fitness in experimental populations of vesicular stomatitis virus. Genetics (1996) 1.11
Natural selection of mutants of vesicular stomatitis virus by cultured cells of Drosophila melanogaster. J Gen Virol (1973) 1.11
A controlled trial of extradural fentanyl in labour. Br J Anaesth (1982) 1.11